Cerebrospinal fluid neuropeptide Y in Prader-Willi syndrome

Developmental Medicine and Child Neurology

Volumn 43, Issue 4, 2001, Pages 286-287

  Åkefeldt, Arne ^a,b   Ekman, Rolf ^a,b   Månsson, Jan Eric ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b SKARABORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALBUMIN; AMINE OXIDASE (FLAVIN CONTAINING); GROWTH HORMONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUROPEPTIDE Y; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; APPETITE; BODY MASS; CEREBROSPINAL FLUID; CHILD; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; EATING DISORDER; FEMALE; GENETIC ASSOCIATION; GROWTH RETARDATION; HEADACHE; HUMAN; INFERTILITY; LETTER; LUMBAR PUNCTURE; MALE; OBESITY; PATERNITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION;

EID: 0035059572     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2001.tb00205.x     Document Type: Letter

References (9)

1. Prader-Willi syndrome: Consensus diagnostic criteria
2. Cerebrospinal fluidmonoamines in Prader-Willi syndrome
3. Is monoamine oxidase activity elevated in Prader-Willi syndrome?
4. A woman with Prader-Willi syndrome gives birth to a healthy baby girl
5. Brain monoamines and peptides: Role in the control of eating behavior
6. Amino acid control of neurotransmitter synthesis and release: Physiological and clinical implications
7. Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: Evidence that NPY may mediate serotonin's effects on food intake
8. Imprinting mutations suggested by abnormal DNA methylation pattern in familial Angelman and Prader-Willi syndromes
9. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively